<DOC>
	<DOCNO>NCT01790997</DOCNO>
	<brief_summary>This 3-arm , prospective , randomize , double-blind , control clinical study , 3 month treatment evaluate efficacy DLBS1033 bleed profile clinical outcome patient acute ischemic stroke compare aspirin clopidogrel , active control .</brief_summary>
	<brief_title>Efficacy DLBS1033 Patients With Acute Ischemic Stroke</brief_title>
	<detailed_description>There 3 group treatment ; group consist 43 subject treatment regimen : - Treatment I : 1 tablet DLBS1033 490 mg thrice daily , meal - Treatment II : 1 tablet aspirin 80 mg daily , meal - Treatment III : 1 tablet clopidogrel 75 mg daily , meal Bleeding profile ( measure INR value , PT , aPTT ) clinical outcome ( measure Gadjah Mada Stroke Scale Barthel Index ) evaluate efficacy investigational drug perform baseline end study ( Month 3rd ) . General condition subject followed-up every month three month study medication . Physiotherapy provide subject assign Physiotherapist .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Male female subject age 2080 year old Having nonbleeding stroke CT scan examination Having stroke attack onset â‰¤ 96 hour Living 100 km RSUP Dr Sardjito Jogjakarta Having recurrence stroke Having Transient Ischemic Attack ( TIA ) Have regularly take antiaggregation agent Having intracerebral subarachnoid bleed stroke Subjects family know stroke symptom appear History haemostasis disorder History surgery within 6 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>DLBS1033</keyword>
	<keyword>Lumbrokinase</keyword>
	<keyword>Acute ischemic stroke</keyword>
	<keyword>Bleeding profile</keyword>
	<keyword>Clinical outcome</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Clopidogrel</keyword>
</DOC>